When Should Relatives Be Screened for a Brain Aneurysm?
At a Glance
Screening is generally discussed when a person has two or more first-degree relatives—parents, siblings, or children—with brain aneurysms, especially ruptures. One affected relative or an inherited condition may call for individualized advice about MRA or CTA.
In this answer
4 sections
⚠️ EMERGENCY WARNING: If you or a relative experience a sudden, severe “worst headache of your life,” new weakness, trouble speaking, a seizure, or a stiff neck, call emergency services immediately. These are potential signs of a ruptured aneurysm and require emergency medical care, not an outpatient screening scan.
If a family member has been diagnosed with a brain aneurysm (an unruptured intracranial aneurysm) or a ruptured aneurysm causing bleeding in the brain (an aneurysmal subarachnoid hemorrhage or aSAH), you may wonder if your relatives should be checked. Medical guidelines generally recommend discussing screening when a family has two or more first-degree relatives (parents, siblings, or children) affected, particularly if they experienced a rupture [1][2]. However, if you are the only person in your family with an aneurysm, routine screening for your relatives is not automatically recommended by current guidelines, though it can still be discussed on a case-by-case basis [2].
The decision to screen for a brain aneurysm involves shared decision-making with a doctor, weighing the potential benefits against the risks of anxiety, false alarms, and invasive follow-up procedures [2].
Who Is Generally Screened?
Medical guidelines and clinical studies categorize the need for family screening based on the family history and the presence of specific genetic syndromes:
- Two or more affected first-degree relatives: If a family has at least two first-degree relatives diagnosed with a brain aneurysm—especially if they had a ruptured aneurysm (aSAH)—the risk to other immediate family members is higher. In these families, doctors typically recommend offering screening [1][2].
- Autosomal Dominant Polycystic Kidney Disease (ADPKD): This inherited condition causes cysts in the kidneys and carries a known higher risk for brain aneurysms. Targeted screening is often recommended for people with ADPKD, particularly if they also have a family history of brain aneurysms [3][4].
- Other Rare Inherited Syndromes: Conditions that affect connective tissue and blood vessels—such as vascular Ehlers-Danlos syndrome, Loeys-Dietz syndrome, Marfan syndrome, or fibromuscular dysplasia—can impact blood vessel health. Relatives with these conditions require genetic counseling and an individualized specialist assessment rather than automatic, population-wide brain scans [5][6].
- Only one affected first-degree relative: If only one person in the family has had an aneurysm, major medical guidelines currently do not mandate routine screening for their relatives [1][2]. However, some risk-modeling studies (research that mathematically simulates health outcomes) suggest there may be a benefit to discussing scans at specific ages, such as 40 and 55 [7]. This remains an individualized choice to be discussed with a doctor.
The Role of Lifestyle Factors
Genetics are only part of a person’s risk. Two major modifiable lifestyle factors significantly increase the chances of an aneurysm forming and rupturing:
- Smoking: Tobacco use is strongly linked to the formation, growth, and potential rupture of brain aneurysms [8][9].
- High blood pressure (Hypertension): Uncontrolled blood pressure places extra stress on blood vessel walls [10].
While these factors should be managed to lower overall health risks, they do not automatically qualify someone for a brain scan on their own [2]. However, if a relative is over 35, smokes, and has high blood pressure, a doctor may consider these factors when evaluating their individual risk and discussing the pros and cons of screening.
How Are Relatives Screened?
When screening is appropriate, doctors use non-invasive imaging to look at the brain’s blood vessels.
- MRA (Magnetic Resonance Angiography): This test uses strong magnets to create images of blood flow. A specific technique called time-of-flight MRA is often preferred for screening because it does not require radiation or an injected contrast dye [11][12].
- CTA (Computed Tomography Angiography): This test uses X-rays and an injected iodine-based contrast dye to view the vessels. It is highly accurate and may be chosen if a person cannot undergo an MRI (e.g., due to severe claustrophobia or metallic implants) or if local expertise favors it, provided their kidney function allows for the contrast dye [13][12].
Do Scans Need to Be Repeated?
In families with a high genetic risk (such as two or more affected relatives), a single clear scan does not guarantee that an aneurysm will never form. Studies of high-risk families have found new aneurysms 5, 10, or 15 years after an initially clear scan [14]. Specialists will often individualize a repeat screening schedule; some medical models suggest scanning every 5 years for certain high-risk groups, but there is no universal timeline that applies to everyone [15][14].
Risks and Downsides of Screening
Before scheduling a scan, a doctor should explain what happens if something is found, as well as the potential downsides [2]:
- Finding a very small aneurysm: Scans often reveal tiny aneurysms. The risk of these rupturing is evaluated based on size, location, shape, age, and patient history. While some small aneurysms are treated with surgery or less invasive endovascular procedures, many are simply monitored. Knowing an aneurysm is present can cause ongoing anxiety [2].
- False positives and invasive tests: Sometimes a scan shows something that looks like an aneurysm but isn’t. This might require additional non-invasive scans or, in select cases, an invasive catheter angiogram (a specialized dye test) to confirm. Invasive tests carry their own small risks and are reserved for specific situations [16].
- Incidental findings: A brain scan might uncover unrelated abnormalities—like a benign cyst—that would never have caused symptoms but may now require medical follow-up [2].
Common questions in this guide
When is screening recommended for relatives of someone with a brain aneurysm?
Do I need a scan if only one first-degree relative has had a brain aneurysm?
What tests are used to screen for a brain aneurysm?
How often should high-risk relatives repeat aneurysm screening?
Do ADPKD or connective-tissue disorders change the need for screening?
Can smoking or high blood pressure mean my relatives should be screened?
What symptoms require emergency care instead of a screening appointment?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Related questions
Show more
Get notified when new evidence is published on brain aneurysm.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.If I am the only person in our family with a brain aneurysm, do my siblings and children still need to be screened, or is their risk low?
- 2.What specific imaging test (MRA or CTA) is most appropriate for screening my relatives based on their medical history and kidney function?
- 3.If my relative's scan is clear, at what age or interval should we consider repeat screening based on our specific family risk?
- 4.Should our family see a genetic counselor to determine if an inherited condition like polycystic kidney disease might be causing the aneurysms?
- 5.If a scan finds a very small aneurysm, how do you decide whether to treat it or monitor it, and what support is available if monitoring causes anxiety?
References
References (16)
- 1
Screening for Intracranial Aneurysms in Individuals with a Positive First-Degree Family History: A Systematic Review.
Van Hoe W, van Loon J, Demeestere J, et al.
World neurosurgery 2021; (151()):235-248.e5 doi:10.1016/j.wneu.2021.02.112.
PMID: 33684573 - 2
Preventive screening for intracranial aneurysms.
Rinkel GJ, Ruigrok YM
International journal of stroke : official journal of the International Stroke Society 2022; (17(1)):30-36 doi:10.1177/17474930211024584.
PMID: 34042530 - 3
Is Regular Screening for Intracranial Aneurysm Necessary in Patients with Autosomal Dominant Polycystic Kidney Disease? A Systematic Review and Meta-analysis.
Zhou Z, Xu Y, Delcourt C, et al.
Cerebrovascular diseases (Basel, Switzerland) 2017; (44(1-2)):75-82 doi:10.1159/000476073.
PMID: 28502970 - 4
Presymptomatic Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease.
Sanchis IM, Shukoor S, Irazabal MV, et al.
Clinical journal of the American Society of Nephrology : CJASN 2019; (14(8)):1151-1160 doi:10.2215/CJN.14691218.
PMID: 31362991 - 5
Prevalence of unruptured intracranial aneurysms according to comorbidities, risk factors, country, and time period: a systematic review and meta-analysis.
Dremel J, Rücker V, Badel C, et al.
The Lancet. Neurology 2026; (25(10)):911-925 doi:10.1016/S1474-4422(26)00276-0.
PMID: 42679840 - 6
Affected twins in the familial intracranial aneurysm study.
Mackey J, Brown RD, Sauerbeck L, et al.
Cerebrovascular diseases (Basel, Switzerland) 2015; (39(2)):82-6 doi:10.1159/000369961.
PMID: 25571891 - 7
A cost-effectiveness analysis of screening for intracranial aneurysms in persons with one first-degree relative with subarachnoid haemorrhage.
Hopmans EM, Ruigrok YM, Bor AS, et al.
European stroke journal 2016; (1(4)):320-329 doi:10.1177/2396987316674862.
PMID: 31008294 - 8
Risk factors for saccular unruptured intracranial aneurysms: a systematic review and meta-analysis.
van Eldik MJA, Ali M, Rietkerken S, et al.
European stroke journal 2026; (11(2)) doi:10.1093/esj/aakaf028.
PMID: 41661032 - 9
A systematic review and meta-analysis of risk factors for unruptured intracranial aneurysm growth.
Jin D, Song C, Leng X, Han P
International journal of surgery (London, England) 2019; (69()):68-76 doi:10.1016/j.ijsu.2019.07.023.
PMID: 31356963 - 10
Modifiable Risk Factors for Intracranial Aneurysm and Aneurysmal Subarachnoid Hemorrhage: A Mendelian Randomization Study.
Karhunen V, Bakker MK, Ruigrok YM, et al.
Journal of the American Heart Association 2021; (10(22)):e022277 doi:10.1161/JAHA.121.022277.
PMID: 34729997 - 11
[Screening and management of intracranial aneurisms in patients with autosomal dominant polycystic kidney disease].
Flahault A, Knebelmann B, Nataf F, et al.
Nephrologie & therapeutique 2017; (13 Suppl 1()):S147-S153 doi:10.1016/j.nephro.2017.01.018.
PMID: 28577737 - 12
Application of Synthetic Time-Of-Flight Magnetic Resonance Angiography-Computed Tomography Fusion Imaging in Preoperative Planning for Aneurysm Clipping Surgery: A Comparative Study with Three-Dimensional Computed Tomography Angiography.
Hou X, Wu T, Li D, Xu R
World neurosurgery 2024; (190()):e302-e309 doi:10.1016/j.wneu.2024.07.119.
PMID: 39033806 - 13
Meta-analysis of computed tomography angiography versus magnetic resonance angiography for intracranial aneurysm.
Chen X, Liu Y, Tong H, et al.
Medicine 2018; (97(20)):e10771 doi:10.1097/MD.0000000000010771.
PMID: 29768368 - 14
Risk Prediction of New Intracranial Aneurysms at Follow-Up Screening in People With a Positive Family History.
Zuurbier CCM, Bourcier R, Constant Dit Beaufils P, et al.
Stroke 2023; (54(4)):1015-1020 doi:10.1161/STROKEAHA.122.041393.
PMID: 36846982 - 15
MR Angiography Screening and Surveillance for Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Cost-effectiveness Analysis.
Malhotra A, Wu X, Matouk CC, et al.
Radiology 2019; (291(2)):400-408 doi:10.1148/radiol.2019181399.
PMID: 30777807 - 16
Flow-mediated pseudolesion mimicking an intracranial aneurysm secondary to cervical internal carotid artery dissection: illustrative case.
Zeng F, Wen F, Fu K, et al.
Journal of neurosurgery. Case lessons 2026; (11(22)).
PMID: 42224738
This page is for informational purposes only and does not constitute medical advice. A neurologist or other qualified clinician should assess your family history, inherited conditions, and screening options.